-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2021 to Q1 2024.
- BriaCell Therapeutics Corp. Net Income (Loss) Attributable to Parent for the quarter ending April 30, 2024 was $1.72M.
- BriaCell Therapeutics Corp. Net Income (Loss) Attributable to Parent for the twelve months ending April 30, 2024 was -$6M, a 67.3% increase year-over-year.
- BriaCell Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.3M, a 24.4% increase from 2022.
- BriaCell Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.8M, a 94.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)